A citation-based method for searching scientific literature

C R M Lammens, E M A Bleiker, N K Aaronson, A Wagner, R H Sijmons, M G E M Ausems, A H J T Vriends, M W G Ruijs, T A M van Os, L Spruijt, E B Gómez García, A Cats, T Nagtegaal, S Verhoef. Fam Cancer 2010
Times Cited: 41







List of co-cited articles
284 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study.
Anita Villani, Uri Tabori, Joshua Schiffman, Adam Shlien, Joseph Beyene, Harriet Druker, Ana Novokmet, Jonathan Finlay, David Malkin. Lancet Oncol 2011
251
56

Genetic testing in Li-Fraumeni syndrome: uptake and psychosocial consequences.
Chantal R M Lammens, Neil K Aaronson, Anja Wagner, Rolf H Sijmons, Margreet G E M Ausems, Annette H J T Vriends, Mariëlle W G Ruijs, Theo A M van Os, Liesbeth Spruijt, Encarna B Gómez García,[...]. J Clin Oncol 2010
73
41

A cancer family syndrome in twenty-four kindreds.
F P Li, J F Fraumeni, J J Mulvihill, W A Blattner, M G Dreyfus, M A Tucker, R W Miller. Cancer Res 1988
966
39

Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations.
Kelly D Gonzalez, Katie A Noltner, Carolyn H Buzin, Dongqing Gu, Cindy Y Wen-Fong, Vu Q Nguyen, Jennifer H Han, Katrina Lowstuter, Jeffrey Longmate, Steve S Sommer,[...]. J Clin Oncol 2009
345
39

Multiple primary cancers in families with Li-Fraumeni syndrome.
M Hisada, J E Garber, C Y Fung, J F Fraumeni, F P Li. J Natl Cancer Inst 1998
351
36

P53 germline mutations in childhood cancers and cancer risk for carrier individuals.
A Chompret, L Brugières, M Ronsin, M Gardes, F Dessarps-Freichey, A Abel, D Hua, L Ligot, M G Dondon, B Bressac-de Paillerets,[...]. Br J Cancer 2000
247
36

Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
Magali Olivier, David E Goldgar, Nayanta Sodha, Hiroko Ohgaki, Paul Kleihues, Pierre Hainaut, Rosalind A Eeles. Cancer Res 2003
299
31

TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
Marielle W G Ruijs, Senno Verhoef, Matti A Rookus, Roelof Pruntel, Annemarie H van der Hout, Frans B L Hogervorst, I Kluijt, Rolf H Sijmons, Cora M Aalfs, Anja Wagner,[...]. J Med Genet 2010
173
31

Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: 11 year follow-up of a prospective observational study.
Anita Villani, Ari Shore, Jonathan D Wasserman, Derek Stephens, Raymond H Kim, Harriet Druker, Bailey Gallinger, Anne Naumer, Wendy Kohlmann, Ana Novokmet,[...]. Lancet Oncol 2016
235
31

Germline p53 mutations in a cohort with childhood sarcoma: sex differences in cancer risk.
Shih-Jen Hwang, Guillermina Lozano, Christopher I Amos, Louise C Strong. Am J Hum Genet 2003
145
29


2009 version of the Chompret criteria for Li Fraumeni syndrome.
Julie Tinat, Gaelle Bougeard, Stéphanie Baert-Desurmont, Stéphanie Vasseur, Cosette Martin, Emilie Bouvignies, Olivier Caron, Brigitte Bressac-de Paillerets, Pascaline Berthet, Catherine Dugast,[...]. J Clin Oncol 2009
203
29

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.
D Malkin, F P Li, L C Strong, J F Fraumeni, C E Nelson, D H Kim, J Kassel, M A Gryka, F Z Bischoff, M A Tainsky. Science 1990
29


Li-fraumeni syndrome.
David Malkin. Genes Cancer 2011
222
29

Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers.
K E Nichols, D Malkin, J E Garber, J F Fraumeni, F P Li. Cancer Epidemiol Biomarkers Prev 2001
237
26

Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li-Fraumeni syndrome cohort.
Phuong L Mai, Ana F Best, June A Peters, Rosamma M DeCastro, Payal P Khincha, Jennifer T Loud, Renée C Bremer, Philip S Rosenberg, Sharon A Savage. Cancer 2016
193
26

F18-fluorodeoxyglucose-positron emission tomography/computed tomography screening in Li-Fraumeni syndrome.
Serena Masciari, Annick D Van den Abbeele, Lisa R Diller, Iryna Rastarhuyeva, Jeffrey Yap, Katherine Schneider, Lisa Digianni, Frederick P Li, Joseph F Fraumeni, Sapna Syngal,[...]. JAMA 2008
64
24

Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.
J M Birch, A L Hartley, K J Tricker, J Prosser, A Condie, A M Kelsey, M Harris, P H Jones, A Binchy, D Crowther. Cancer Res 1994
409
24

Revisiting Li-Fraumeni Syndrome From TP53 Mutation Carriers.
Gaëlle Bougeard, Mariette Renaux-Petel, Jean-Michel Flaman, Camille Charbonnier, Pierre Fermey, Muriel Belotti, Marion Gauthier-Villars, Dominique Stoppa-Lyonnet, Emilie Consolino, Laurence Brugières,[...]. J Clin Oncol 2015
290
24


Sensitivity and predictive value of criteria for p53 germline mutation screening.
A Chompret, A Abel, D Stoppa-Lyonnet, L Brugiéres, S Pagés, J Feunteun, C Bonaïti-Pellié. J Med Genet 2001
194
21

Younger age of cancer initiation is associated with shorter telomere length in Li-Fraumeni syndrome.
Uri Tabori, Sonia Nanda, Harriet Druker, Jodi Lees, David Malkin. Cancer Res 2007
103
19

Germline mutations in the TP53 gene.
R A Eeles. Cancer Surv 1995
147
19

Li-Fraumeni syndrome: cancer risk assessment and clinical management.
Kate A McBride, Mandy L Ballinger, Emma Killick, Judy Kirk, Martin H N Tattersall, Rosalind A Eeles, David M Thomas, Gillian Mitchell. Nat Rev Clin Oncol 2014
133
19

Psychological functioning in persons considering genetic counseling and testing for Li-Fraumeni syndrome.
Susan K Peterson, Rebecca D Pentz, Salma K Marani, Patricia A Ward, Amie M Blanco, Denise LaRue, Kristen Vogel, Tamara Solomon, Louise C Strong. Psychooncology 2008
28
28

Relative frequency and morphology of cancers in carriers of germline TP53 mutations.
J M Birch, R D Alston, R J McNally, D G Evans, A M Kelsey, M Harris, O B Eden, J M Varley. Oncogene 2001
299
17

Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients.
E D Lustbader, W R Williams, M L Bondy, S Strom, L C Strong. Am J Hum Genet 1992
112
17

A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.
Gareth L Bond, Wenwei Hu, Elisabeth E Bond, Harlan Robins, Stuart G Lutzker, Nicoleta C Arva, Jill Bargonetti, Frank Bartel, Helge Taubert, Peter Wuerl,[...]. Cell 2004
993
17

Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort.
Serena Masciari, Deborah A Dillon, Michelle Rath, Mark Robson, Jeffrey N Weitzel, Judith Balmana, Stephen B Gruber, James M Ford, David Euhus, Alexandra Lebensohn,[...]. Breast Cancer Res Treat 2012
94
17

Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome.
Steve Heymann, Suzette Delaloge, Arslane Rahal, Olivier Caron, Thierry Frebourg, Lise Barreau, Corinne Pachet, Marie-Christine Mathieu, Hugo Marsiglia, Céline Bourgier. Radiat Oncol 2010
108
17

Prevalence of early onset colorectal cancer in 397 patients with classic Li-Fraumeni syndrome.
Patricia Wong, Sigitas J Verselis, Judy E Garber, Katherine Schneider, Lisa DiGianni, David H Stockwell, Frederick P Li, Sapna Syngal. Gastroenterology 2006
73
17

Li-Fraumeni syndrome: report of a clinical research workshop and creation of a research consortium.
Phuong L Mai, David Malkin, Judy E Garber, Joshua D Schiffman, Jeffrey N Weitzel, Louise C Strong, Oliver Wyss, Luana Locke, Von Means, Maria Isabel Achatz,[...]. Cancer Genet 2012
56
17

Joint effects of germ-line p53 mutation and sex on cancer risk in Li-Fraumeni syndrome.
Chih-Chieh Wu, Sanjay Shete, Christopher I Amos, Louise C Strong. Cancer Res 2006
57
17

Anaplastic rhabdomyosarcoma in TP53 germline mutation carriers.
Simone Hettmer, Natasha M Archer, Gino R Somers, Ana Novokmet, Amy J Wagers, Lisa Diller, Carlos Rodriguez-Galindo, Lisa A Teot, David Malkin. Cancer 2014
61
17

Germline Mutations in Predisposition Genes in Pediatric Cancer.
Jinghui Zhang, Michael F Walsh, Gang Wu, Michael N Edmonson, Tanja A Gruber, John Easton, Dale Hedges, Xiaotu Ma, Xin Zhou, Donald A Yergeau,[...]. N Engl J Med 2015
539
17

Psychosocial morbidity in TP53 mutation carriers: is whole-body cancer screening beneficial?
Kate A McBride, Mandy L Ballinger, Timothy E Schlub, Mary-Anne Young, Martin H N Tattersall, Judy Kirk, Ros Eeles, Emma Killick, Leslie G Walker, Sue Shanley,[...]. Fam Cancer 2017
26
26

An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma.
R C Ribeiro, F Sandrini, B Figueiredo, G P Zambetti, E Michalkiewicz, A R Lafferty, L DeLacerda, M Rabin, C Cadwell, G Sampaio,[...]. Proc Natl Acad Sci U S A 2001
344
14

TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors.
Uri Tabori, Adam Shlien, Berivan Baskin, Sarah Levitt, Peter Ray, Noa Alon, Cynthia Hawkins, Eric Bouffet, Malgorzata Pienkowska, Lucie Lafay-Cousin,[...]. J Clin Oncol 2010
102
14

Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study.
Judy Mouchawar, Christopher Korch, Tim Byers, Todd M Pitts, Efang Li, Margaret R E McCredie, Graham G Giles, John L Hopper, Melissa C Southey. Cancer Res 2010
66
14

Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families.
G Bougeard, R Sesboüé, S Baert-Desurmont, S Vasseur, C Martin, J Tinat, L Brugières, A Chompret, B Bressac de Paillerets, D Stoppa-Lyonnet,[...]. J Med Genet 2008
145
14

Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database.
Audrey Petitjean, Ewy Mathe, Shunsuke Kato, Chikashi Ishioka, Sean V Tavtigian, Pierre Hainaut, Magali Olivier. Hum Mutat 2007
14

Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome.
Adam Shlien, Uri Tabori, Christian R Marshall, Malgorzata Pienkowska, Lars Feuk, Ana Novokmet, Sonia Nanda, Harriet Druker, Stephen W Scherer, David Malkin. Proc Natl Acad Sci U S A 2008
138
14

Germ-line transmission of a mutated p53 gene in a cancer-prone family with Li-Fraumeni syndrome.
S Srivastava, Z Q Zou, K Pirollo, W Blattner, E H Chang. Nature 1990
14

Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome.
G Bougeard, S Baert-Desurmont, I Tournier, S Vasseur, C Martin, L Brugieres, A Chompret, B Bressac-de Paillerets, D Stoppa-Lyonnet, C Bonaiti-Pellie,[...]. J Med Genet 2006
167
14

Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors.
Gislaine Custódio, Guilherme A Parise, Nilton Kiesel Filho, Heloisa Komechen, Cesar C Sabbaga, Roberto Rosati, Leila Grisa, Ivy Z S Parise, Mara A D Pianovski, Carmem M C M Fiori,[...]. J Clin Oncol 2013
109
14

High frequency of de novo mutations in Li-Fraumeni syndrome.
K D Gonzalez, C H Buzin, K A Noltner, D Gu, W Li, D Malkin, S S Sommer. J Med Genet 2009
97
14

Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families.
Kory W Jasperson, Wendy Kohlmann, Amanda Gammon, Heidi Slack, Luke Buchmann, Jason Hunt, Anne C Kirchhoff, Henry Baskin, Akram Shaaban, Joshua D Schiffman. Fam Cancer 2014
62
14

Hereditary cancer risk assessment in a pediatric oncology follow-up clinic.
Sara Knapke, Rajaram Nagarajan, Judy Correll, Debra Kent, Karen Burns. Pediatr Blood Cancer 2012
61
14

Easing the Burden: Describing the Role of Social, Emotional and Spiritual Support in Research Families with Li-Fraumeni Syndrome.
June A Peters, Regina Kenen, Renee Bremer, Shannon Givens, Sharon A Savage, Phuong L Mai. J Genet Couns 2016
15
40


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.